Linked Life Data

16877728

Source:http://linkedlifedata.com/resource/pubmed/id/16877728

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
2006-7-31
pubmed:abstractText
To study the prognostic significance of the presence of breast cancer-specific mRNA transcripts in peripheral blood (PB), defined by serial analysis of gene expression, in high-risk breast cancer (HRBC) patients undergoing high-dose chemotherapy after receiving adjuvant chemotherapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Surface, http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/EGP-2 antigen, human, http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Keratins, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins, http://linkedlifedata.com/resource/pubmed/chemical/PSEN2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Presenilin-2, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/RNA Precursors, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Thiotepa, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/phospholamban
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3611-8
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16877728-Humans, pubmed-meshheading:16877728-Follow-Up Studies, pubmed-meshheading:16877728-Breast Neoplasms, pubmed-meshheading:16877728-Aged, pubmed-meshheading:16877728-Keratins, pubmed-meshheading:16877728-Prognosis, pubmed-meshheading:16877728-Female, pubmed-meshheading:16877728-Treatment Outcome, pubmed-meshheading:16877728-Adult, pubmed-meshheading:16877728-Retrospective Studies, pubmed-meshheading:16877728-Middle Aged, pubmed-meshheading:16877728-Membrane Proteins, pubmed-meshheading:16877728-RNA, Messenger, pubmed-meshheading:16877728-Cyclophosphamide, pubmed-meshheading:16877728-Thiotepa, pubmed-meshheading:16877728-Fluorouracil, pubmed-meshheading:16877728-RNA, Neoplasm, pubmed-meshheading:16877728-Multivariate Analysis, pubmed-meshheading:16877728-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16877728-Risk Factors, pubmed-meshheading:16877728-Risk Assessment, pubmed-meshheading:16877728-Predictive Value of Tests, pubmed-meshheading:16877728-Antigens, Surface, pubmed-meshheading:16877728-Tumor Markers, Biological, pubmed-meshheading:16877728-Survival Analysis, pubmed-meshheading:16877728-Chemotherapy, Adjuvant, pubmed-meshheading:16877728-Odds Ratio, pubmed-meshheading:16877728-Doxorubicin, pubmed-meshheading:16877728-RNA Precursors, pubmed-meshheading:16877728-Calcium-Binding Proteins, pubmed-meshheading:16877728-Paclitaxel, pubmed-meshheading:16877728-Epirubicin, pubmed-meshheading:16877728-Carboplatin, pubmed-meshheading:16877728-Receptor, erbB-2
More...